Healthcare provider profile · identity verified

Todd Rafferty, M.D.

Family Practice · CUYAHOGA FALLS, OH · NPI 1780746974

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	442	153
Pregabalin	Pregabalin	223	41
Amlodipine Besylate	Amlodipine Besylate	185	58
Metformin Hcl	Metformin Hcl	183	61
Gabapentin	Gabapentin	178	37
Levothyroxine Sodium	Levothyroxine Sodium	178	53
Albuterol Sulfate Hfa	Albuterol Sulfate	171	63
Furosemide	Furosemide	148	48
Lisinopril	Lisinopril	148	50
Tamsulosin Hcl	Tamsulosin Hcl	139	41
Omeprazole	Omeprazole	137	48
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	122	36
Alprazolam	Alprazolam	111	13
Metoprolol Succinate	Metoprolol Succinate	111	38
Jardiance	Empagliflozin	100	26
Tizanidine Hcl	Tizanidine Hcl	97	25
Ozempic	Semaglutide	96	20
Losartan Potassium	Losartan Potassium	92	35
Eliquis	Apixaban	89	22
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	88	29
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	83	19
Clonazepam	Clonazepam	82	14
Pantoprazole Sodium	Pantoprazole Sodium	82	33
Sertraline Hcl	Sertraline Hcl	82	28
Rosuvastatin Calcium	Rosuvastatin Calcium	78	25
Lorazepam	Lorazepam	74	13
Montelukast Sodium	Montelukast Sodium	71	20
Zolpidem Tartrate	Zolpidem Tartrate	71	19
Potassium Chloride	Potassium Chloride	69	17
Tramadol Hcl	Tramadol Hcl	69	30
Trazodone Hcl	Trazodone Hcl	69	16
Trulicity	Dulaglutide	69	14
Clopidogrel	Clopidogrel Bisulfate	65	18
Fluoxetine Hcl	Fluoxetine Hcl	61	17
Oxybutynin Chloride Er	Oxybutynin Chloride	61	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	59	16
Metoprolol Tartrate	Metoprolol Tartrate	58	20
Glimepiride	Glimepiride	57	17
Spironolactone	Spironolactone	56	12
Carvedilol	Carvedilol	54	21
Hydrochlorothiazide	Hydrochlorothiazide	54	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	18
Chlorthalidone	Chlorthalidone	50	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	15
Promethazine Hcl	Promethazine Hcl	50	suppressed
Prednisone	Prednisone	49	27
Clonidine Hcl	Clonidine Hcl	47	suppressed
Duloxetine Hcl	Duloxetine Hcl	47	19
Pioglitazone Hcl	Pioglitazone Hcl	45	18
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	44	suppressed
Simvastatin	Simvastatin	43	16
Famotidine	Famotidine	42	15
Fluticasone Propionate	Fluticasone Propionate	42	19
Hydralazine Hcl	Hydralazine Hcl	40	suppressed
Valacyclovir	Valacyclovir Hcl	40	15
Meloxicam	Meloxicam	39	14
Ezetimibe	Ezetimibe	36	11
Allopurinol	Allopurinol	34	14
Pravastatin Sodium	Pravastatin Sodium	34	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	33	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	32	suppressed
Farxiga	Dapagliflozin Propanediol	32	11
Ibuprofen	Ibuprofen	32	suppressed
Mounjaro	Tirzepatide	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	suppressed
Metformin Hcl Er	Metformin Hcl	31	suppressed
Atenolol	Atenolol	28	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	24
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	27	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	17
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Finasteride	Finasteride	23	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Diazepam	Diazepam	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Varenicline Tartrate	Varenicline Tartrate	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	20	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Azithromycin	Azithromycin	19	14
Celecoxib	Celecoxib	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Fluconazole	Fluconazole	19	13
Meclizine Hcl	Meclizine Hcl	19	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Loperamide	Loperamide Hcl	17	suppressed
Torsemide	Torsemide	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	16	suppressed
Cephalexin	Cephalexin	16	12
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	12
Nystatin	Nystatin	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Megestrol Acetate	Megestrol Acetate	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Valsartan	Valsartan	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Propafenone Hcl Er	Propafenone Hcl	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Ibu	Ibuprofen	12	suppressed
Insulin Lispro	Insulin Lispro	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Omnipod 5 Dexg7g6 Pods (Gen 5)	Insulin Pump Cart,auto,bt,g6/7	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Topiramate	Topiramate	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Baclofen	Baclofen	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Repatha Sureclick	Evolocumab	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error